Skip to main content

Table 3 Estimated effect (EE) and effect size (ES) of early engagement in Learning Collaboratives

From: Expanding access to medications for opioid use disorder in primary care clinics: an evaluation of common implementation strategies and outcomes

 

Early engagement with a prescriber vs. Early engagement without a prescriber

Q1

Q2

Q3

Reach

Number of patients with OUD

  EE (95% CI)

22.77 (−1441.20, 1486.74)

8.82 (−696.67, 714.31)

−5.13 (−1468.98, 1458.72)

  ES (95% CI)

0.32 (−20.34, 20.99)

0.12 (−9.83, 10.08)

−0.07 (−20.74, 20.59)

Number of patients prescribed MOUD

  EE (95% CI)

6.19 (−47.23, 59.60)

1.97 (−34.05, 38.00)

−2.25 (−55.66, 51.17)

  ES (95% CI)

0.37 (−2.79, 3.53)

0.12 (−2.02, 2.25)

−0.13 (−3.29, 3.03)

Percent of patients prescribed MOUDa

  EE (95% CI)

−8.02 (−12.83, −3.20)

0.31 (−3.59, 4.22)

8.65 (1.39, 15.90)

  ES (95% CI)

−0.22 (−0.36, −0.09)

0.01 (−0.10, 0.12)

0.24 (0.04, 0.44)

Adoption

Number of prescribers

  EE (95% CI)

0.35 (−3.99, 4.68)

1.37 (−2.41, 5.15)

2.40 (−1.93, 6.73)

  ES (95% CI)

0.08 (−0.89, 1.04)

0.31 (−0.54, 1.15)

0.54 (−0.43, 1.50)

Number of x-waivered prescribers

  EE (95% CI)

0.29 (−1.47, 2.05)

0.75 (−0.76, 2.26)

1.21 (−0.54, 2.97)

  ES (95% CI)

0.10 (−0.51, 0.71)

0.26 (−0.26, 0.79)

0.42 (−0.19, 1.03)

Number of active x-waivered prescribers

  EE (95% CI)

0.36 (−0.28, 1.00)

0.73 (0.22, 1.25)

1.10 (0.46, 1.74)

  ES (95% CI)

0.20 (−0.16, 0.55)

0.40 (0.12, 0.69)

0.61 (0.25, 0.96)

Percent of x-waivered prescribers

  EE (95% CI)

−1.73 (−2.76, −0.70)

−1.94 (−2.85, −1.02)

−2.14 (−3.18, −1.11)

  ES (95% CI)

−0.08 (−0.13, −0.03)

−0.09 (−0.13, −0.05)

−0.10 (−0.14 −0.05)

Implementation quality

IMAT implementation quality

  EE (95% CI)

0.33 (0.25, 0.42)

  ES (95% CI)

0.55 (0.41, 0.69)

  1. aPrimary outcome; EE and ES in bold indicated 95% CI did not cross zero